BFBIO Share Price Performance
PK₨0
-160.15 (-100.00%)
Price PK₨0
Fair ValuePK₨554.04
Share Pricen/a
BF Biosciences Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 18 Fair Values set on narratives written by author
BFBIO Community Narratives
JI
Fair Value PK₨554.04 73.3% undervalued intrinsic discount
BFBIO is a long-duration growth platform
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
BFBIO is a long-duration growth platform
BF Biosciences is evolving into one of Pakistan’s most promising long-term pharma compounders, driven by rapid growth in specialty injectables and the early leadership it has built in locally manufactured GLP-1 products. The company’s recent launch of Zeptide® (tirzepatide) and continued scale-up of semaglutide-based diabetes and obesity products gives it exposure to one of the fastest-growing therapy segments globally.Read more
26
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
JI
PK₨554.04
73.3% undervalued intrinsic discount
Fair Value
Revenue
60% p.a.
Profit Margin
7.28%
Future PE
22.78x
Price in 2031
PK₨1.62k
Trending Discussion
Recently Updated Narratives
JI
BFBIO is a long-duration growth platform
Fair Value: PK₨554.04 73.3% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
BF Biosciences Limited Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 27, 2026
- 6.78
- 40.29%
- 7.28%
- 32.5%
About BFBIO
- Founded
- 2006
- Employees
- 535
- CEO
- WebsiteView website
BF Biosciences Limited, a biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products in Pakistan, Nepal, Afghanistan, Mauritania, Switzerland, and internationally. The company offers pharmaceutical products for various therapeutic areas, including cardiometabolic disorders, cardiology, diabetes, anti-obesity, hepatology, gastroenterology, chronic kidney diseases, dermatology, antifungal treatments, antibiotics, antivirals, rheumatoid arthritis, nephrology, and oncology. It also provides injectables in vials, ampoules, and pre-filled syringes forms. In addition, the company is involved in the sale of medical devices; and toll manufacturing services for pharmaceutical products to other pharmaceutical companies. It exports its products. The company was incorporated in 2006 and is headquartered in Lahore, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited.